NOVO.B.DK

434

-1.91%↓

GMAB.DK

1,361.5

-0.66%↓

HLUNB.DK

34.14

-1.22%↓

ZEAL.DK

368.4

+1.13%↑

AMBUB.DK

97.3

+1.57%↑

NOVO.B.DK

434

-1.91%↓

GMAB.DK

1,361.5

-0.66%↓

HLUNB.DK

34.14

-1.22%↓

ZEAL.DK

368.4

+1.13%↑

AMBUB.DK

97.3

+1.57%↑

NOVO.B.DK

434

-1.91%↓

GMAB.DK

1,361.5

-0.66%↓

HLUNB.DK

34.14

-1.22%↓

ZEAL.DK

368.4

+1.13%↑

AMBUB.DK

97.3

+1.57%↑

NOVO.B.DK

434

-1.91%↓

GMAB.DK

1,361.5

-0.66%↓

HLUNB.DK

34.14

-1.22%↓

ZEAL.DK

368.4

+1.13%↑

AMBUB.DK

97.3

+1.57%↑

NOVO.B.DK

434

-1.91%↓

GMAB.DK

1,361.5

-0.66%↓

HLUNB.DK

34.14

-1.22%↓

ZEAL.DK

368.4

+1.13%↑

AMBUB.DK

97.3

+1.57%↑

Search

Coloplast A-S (Class B)

Closed

603.4 0.4

Overview

Share price change

24h

Current

Min

577

Max

611.4

Key metrics

By Trading Economics

Income

-132M

912M

Sales

-96M

6.9B

P/E

Sector Avg

29.385

39.564

EPS

5.45

Dividend yield

3.66

Profit margin

13.16

Employees

16,741

EBITDA

2.2B

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+11.86% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.66%

2.40%

Next Earnings

19 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-24B

134B

Previous open

603

Previous close

603.4

Coloplast A-S (Class B) Chart

Past performance is not a reliable indicator of future results.

Related News

15 Jul 2025, 23:41 UTC

Market Talk

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15 Jul 2025, 23:40 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15 Jul 2025, 23:05 UTC

Market Talk

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15 Jul 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 Jul 2025, 21:36 UTC

Market Talk

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15 Jul 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15 Jul 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 Jul 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 Jul 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

15 Jul 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15 Jul 2025, 20:07 UTC

Earnings

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15 Jul 2025, 20:06 UTC

Market Talk

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15 Jul 2025, 19:54 UTC

Market Talk

Global Equities Roundup: Market Talk

15 Jul 2025, 19:54 UTC

Market Talk

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15 Jul 2025, 19:38 UTC

Market Talk

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15 Jul 2025, 19:09 UTC

Market Talk

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15 Jul 2025, 19:07 UTC

Market Talk

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15 Jul 2025, 19:03 UTC

Market Talk

Gold Slips as Big Buyers Pull Back -- Market Talk

15 Jul 2025, 18:32 UTC

Acquisitions, Mergers, Takeovers

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 Jul 2025, 18:31 UTC

Acquisitions, Mergers, Takeovers

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15 Jul 2025, 18:13 UTC

Market Talk

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15 Jul 2025, 17:40 UTC

Market Talk

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15 Jul 2025, 17:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 Jul 2025, 17:25 UTC

Acquisitions, Mergers, Takeovers

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15 Jul 2025, 17:24 UTC

Market Talk

Dollar Gains Strength After Inflation Data -- Market Talk

15 Jul 2025, 16:49 UTC

Market Talk

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15 Jul 2025, 16:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 Jul 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 Jul 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 Jul 2025, 15:42 UTC

Market Talk

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Peer Comparison

Price change

Coloplast A-S (Class B) Forecast

Price Target

By TipRanks

11.86% upside

12 Months Forecast

Average 901.38 DKK  11.86%

High 1,056 DKK

Low 720 DKK

Based on 8 Wall Street analysts offering 12 month price targets forColoplast A-S (Class B) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

2

Buy

4

Hold

2

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.